Search - tctmd.com

Displaying 41 - 60 of 294

Sort: Relevancy | Date

Presentation THT 2026

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Presenter: Grant Reed

March 03, 2026

Presentation THT 2026

Advanced Hemodynamics To Guide Recovery, Prognosis, and Clinical Care

Presenter: Michele Esposito

March 03, 2026

Presentation THT 2026

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

Presenter: Nelson Wang

March 03, 2026

Presentation THT 2026

The Role of Provocative Hemodynamic Testing in Clinical Practice

Presenter: Susanna S. Mak

March 03, 2026

Presentation THT 2026

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Presenter: Benjamin Hibbert

March 03, 2026

Presentation THT 2026

Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial

Presenter: Elric Zweck

March 03, 2026

Presentation THT 2026

Feasibility and Safety of Clinician-Directed Patient Self-Management of Congestion Using an Implantable Inferior Vena Cava Sensor

Presenter: Nir Uriel

March 03, 2026

Presentation THT 2026

Beyond Clinical Calculations — Machine Learning of Hemodynamic Waveforms

Presenter: Steven Hsu

March 03, 2026

Presentation THT 2026

Early Cardiac Contractility Modulation (CCM) Therapy Use Reduces Heart Failure-Related Hospitalization

Presenter: Daniel Burkhoff

March 03, 2026

Presentation THT 2026

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

Presenter: G. Michael Felker

March 03, 2026

Presentation THT 2026

Prognostic Value of NT-proBNP in Patients Undergoing Tricuspid Valve Transcatheter Edge-to-Edge Repair: The EuroTR Registry

Presenter: Jennifer von Stein

March 03, 2026

Presentation THT 2026

Clinical Evaluation Of The Vsling™ Device For Ventricular Repair In Patients With Heart Failure

Presenter: Gregg W. Stone

March 03, 2026

Presentation THT 2026

AI in the Trenches: Lessons From Clinical Trial Optimization

Presenter: Jonathan Cunningham

March 02, 2026

Presentation THT 2026

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Presenter: Tariq Ahmad

March 02, 2026

Presentation THT 2026

Artificial Intelligence: Framing the Future of HF Diagnostics and Clinical Decision Making

Presenter: Anuradha (Anu) Lala-Trindade (Lala)

March 02, 2026

Presentation THT 2026

Clinical Viewpoint: Fallout from the IABP Shock II and Alt-Shock Studies

Presenter: Joyce Wanglee Wald

March 02, 2026

Presentation THT 2026

HeartCon: Pioneering VAD Development in China

Presenter: Xiaocheng Liu

March 02, 2026

Presentation THT 2026

Predicted vs. Observed 3-Year Mortality in the ALT FLOW Early Feasibility Study Cohort

Presenter: Javed Butler

March 02, 2026

Presentation THT 2026

Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension

Presenter: Yogesh Reddy

March 02, 2026

Presentation THT 2026

Effect of Cardiac Contractility Modulation (CCM) Therapy on Reverse Remodeling in Heart Failure Patients with Left Ventricular Ejection Fraction 25-45%

Presenter: Rami Kahwash

March 02, 2026

Advertisement

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Advanced Hemodynamics To Guide Recovery, Prognosis, and Clinical Care

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

The Role of Provocative Hemodynamic Testing in Clinical Practice

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial

Feasibility and Safety of Clinician-Directed Patient Self-Management of Congestion Using an Implantable Inferior Vena Cava Sensor

Beyond Clinical Calculations — Machine Learning of Hemodynamic Waveforms

Early Cardiac Contractility Modulation (CCM) Therapy Use Reduces Heart Failure-Related Hospitalization

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

Prognostic Value of NT-proBNP in Patients Undergoing Tricuspid Valve Transcatheter Edge-to-Edge Repair: The EuroTR Registry

Clinical Evaluation Of The Vsling™ Device For Ventricular Repair In Patients With Heart Failure

AI in the Trenches: Lessons From Clinical Trial Optimization

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Artificial Intelligence: Framing the Future of HF Diagnostics and Clinical Decision Making

Clinical Viewpoint: Fallout from the IABP Shock II and Alt-Shock Studies

HeartCon: Pioneering VAD Development in China

Predicted vs. Observed 3-Year Mortality in the ALT FLOW Early Feasibility Study Cohort

Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension

Effect of Cardiac Contractility Modulation (CCM) Therapy on Reverse Remodeling in Heart Failure Patients with Left Ventricular Ejection Fraction 25-45%

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content